Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium
Titel:
Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium
Auteur:
Pasqualini, Claudia Rubino, Jonathan Brard, Caroline Cassard, Lydie André, Nicolas Rondof, Windy Scoazec, Jean-Yves Marchais, Antonin Nebchi, Souad Boselli, Lisa Grivel, Jonathan Aerts, Isabelle Thebaud, Estelle Paoletti, Xavier Minard-Colin, Véronique Vassal, Gilles Geoerger, Birgit